Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment

@article{Youssef2011CardiacSA,
  title={Cardiac sarcoidosis: applications of imaging in diagnosis and directing treatment},
  author={G. Youssef and R. Beanlands and D. Birnie and P. Nery},
  journal={Heart},
  year={2011},
  volume={97},
  pages={2078 - 2087}
}
Sarcoidosis has been reported to have a particular predilection for adults under the age of 40 years.w1 The incidence of sarcoidosis varies greatly by ethnicity and region, occurring in 3 to 20 per 100 000 for whites and 35.5 to 80 per 100 000 for blacks.1 Scandinavian populations have been reported as having a higher prevalence than other Caucasian regions.w2 The incidence of cardiac sarcoidosis (CS) also varies by the type of study performed, whether clinical or autopsy study, with clinical… Expand
Cardiac Sarcoidosis: Is it More Common in Men?
TLDR
Cardiac involvement in sarcoidosis was diagnosed in the similar percentage as in previously published data but was significantly more frequently in men. Expand
Assessment of Cardiac Sarcoidosis with Advanced Imaging Modalities
Sarcoidosis is a chronic systemic disease of unknown etiology that is characterized by the presence of noncaseating epithelioid granulomas, usually in multiple organs. Several studies have shown thatExpand
Cardiac SarcoidosisCLINICAL PERSPECTIVE
TLDR
The detection rate of CS has increased markedly in Finland over the last 25 years, and with current therapy, the prognosis of CS appears better than generally considered, but patients presenting with heart failure still have poor long-term outcome. Expand
Cardiac sarcoidosis
TLDR
Clinically manifest disease is not the whole story of sarcoid heart disease, however, and up to one-fourth of patients with extracardiac sarCOidosis free of cardiac symptoms have myocardial involvement on magnetic resonance imaging. Expand
Management of cardiac sarcoidosis – A practical guide
TLDR
An overview of presentation, diagnosis, and treatment of cardiac sarcoidosis, with special emphasis on the use of algorithms applicable in routine clinical practice is presented. Expand
2 Blankstein and Waller Use of Imaging in Cardiac Sarcoidosis
Abstract—Sarcoidosis is a multisystem disorder of unknown cause, and cardiac sarcoidosis affects at least 25% of patients and accounts for substantial mortality and morbidity from this disease.Expand
Echocardiography in Sarcoidosis
TLDR
Increased sensitivity of echocardiography has facilitated the use of other techniques to establish the presence of CS, and imaging plays a role in diagnosis as well as for follow-up. Expand
Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study.
TLDR
With current therapy, the prognosis of CS appears better than generally considered, but patients presenting with heart failure still have poor long-term outcome, and the detection rate of CS has increased markedly over the last 25 years. Expand
Cardiac sarcoidosis: diagnosis and management.
TLDR
Current trends in the pathophysiology, diagnosis and management of cardiac sarcoidosis will be reviewed focusing on published research and latest guidelines and a management algorithm is proposed. Expand
Cardiovascular Complications and Management in Sarcoidosis: A Review
TLDR
The treatment of sarcoidosis involves systemic steroids with or without other immunomodulatory medications, and continued imaging follow-up to document either improvement or continued inflammatory activity. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 25 REFERENCES
Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing.
TLDR
A structured clinical assessment incorporating advanced cardiac imaging with PET scanning or CMRI is more sensitive than the established criteria for the identification of CS in ambulatory patients with preserved cardiac function, who appear to be at low risk for short-term mortality. Expand
Cardiac Sarcoid: A Clinicopathologic Study of 84 Unselected Patients with Systemic Sarcoidosis
TLDR
The results show that although myocardial involvement occurs in at least 25% of patients with sarcoid, it most often involves a small portion of myocardium and is clinically silent, and since some of the 61 patients in whommyocardial lesions were not identified may still have had small microscopic granulomas, the true incidence of my Cardiac Sarcoid may be even greater than suggested. Expand
Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS).
TLDR
A significant elevated risk of sarcoidosis was observed among first- and second-degree relatives of sarCOidosis cases compared with relatives of matched control subjects. Expand
Detection of Myocardial Damage in Patients With Sarcoidosis
TLDR
In patients with sarcoidosis, DE-CMR is more than twice as sensitive for cardiac involvement as current consensus criteria, and appears to be associated with future adverse events including cardiac death. Expand
A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis.
TLDR
Transplant-free survival is better for patients with CS than for IGCM diagnosed by EMB, and presentation with heart failure predicted I GCM, and presentation with heart block or more than nine weeks of symptoms predicted CS. Expand
Epidemiology of sarcoidosis: recent advances and future prospects.
TLDR
The epidemiology of sarcoidosis has a promising future that should eventually provide the answers to the etiologic origins of this complex disease and case-only methods may be useful in identifying recent acute exposures linked to disease, genetic variants of risk, and gene-environment interactions. Expand
The Work‐Up and Management of Patients with Apparent or Subclinical Cardiac Sarcoidosis: With Emphasis on the Associated Heart Rhythm Abnormalities
TLDR
In patients with newly diagnosed AV block and/or ventricular tachycardia, cardiac sarcoidosis should always be considered in the differential diagnosis and cardiac resynchronization therapy (CRT) should be selected for severe heart failure patients who have class III or IV heart failure. Expand
Cardiac Sarcoidosis and Giant Cell Myocarditis as Causes of Atrioventricular Block in Young and Middle-Aged Adults
TLDR
CS and GCM explain ≥25% of initially unexplained AVB in young and middle-aged adults undergoing pacemaker implantation for AVB, and these patients are at high risk for adverse cardiac events. Expand
Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block.
TLDR
The findings suggest that corticosteroids are useful in the treatment of cardiac sarcoidosis complicated by atrioventricular block but with normal cardiac function, however, these agents must be used with caution, with the maintenance dose kept as low as possible. Expand
A case control etiologic study of sarcoidosis: environmental and occupational risk factors.
TLDR
Several exposures associated with sarcoidosis risk were identified, including insecticides, agricultural employment, and microbial bioaerosols, which were identified in univariable and multivariable analyses. Expand
...
1
2
3
...